Annals of Nuclear Medicine 11/2022

16.08.2022 | Original Article

Identification of patients with Graves’ disease who benefit from high-dose radioactive iodine therapy

Shiro Watanabe, Shozo Okamoto, Kazumasa Akikawa, Noriyuki Miyamoto, Miyuki Okamura-Kawasaki, Yuko Uchiyama, Junki Takenaka, Takuya Toyonaga, Kenji Hirata, Kohsuke Kudo

15.08.2022 | Original Article

PD1 blockade alters cell-cycle distribution and affects 3′-deoxy-3′-[18F]fluorothymidine uptake in a mouse CT26 tumor model

Motofumi Suzuki, Takuma Matsuda, Kohei Nakajima, Yuta Yokouchi, Yuji Kuge, Mikako Ogawa

01.09.2022 | Original Article

New index to assess the extent of bone disease in patients with prostate cancer using SPECT/CT

Hajime Ichikawa, Takayuki Shibutani, Masahisa Onoguchi, Yuki Taniguchi

03.09.2022 | Original Article

Semiquantitative analysis using whole-body dynamic F-18 fluoro-2-deoxy-glucose–positron emission tomography to differentiate between benign and malignant lesions

Mirei Watanabe, Hiroki Kato, Daisuke Katayama, Fumihiko Soeda, Keiko Matsunaga, Tadashi Watabe, Mitsuaki Tatsumi, Eku Shimosegawa, Noriyuki Tomiyama

23.08.2022 | Original Article

Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment

Tugba Akin Telli, Salih Ozguven, Ozkan Alan, Nuh Filizoglu, Mehmet Akif Ozturk, Nisanur Sariyar, Selver Isik, Rukiye Arikan, Nazim Can Demircan, Tugba Basoglu, Ilknur Alsan Cetin, Tunc Ones, Ozlem Ercelep, Faysal Dane, Perran Fulden Yumuk

12.09.2022 | Original Article

[99mTc]-labeling and evaluation of a new linear peptide for imaging of glioblastoma as a αvβ3-positive tumor

Sajad Kaihani, Nourollah Sadeghzadeh, Saeid Abediankenari, Seyed Mohammad Abedi

Open Access 25.09.2022 | Original Article

Methods of calculating 123I-β-methyl-P-iodophenyl-pentadecanoic acid washout rates in triglyceride deposit cardiomyovasculopathy

Zhuoqing Chen, Kenichi Nakajima, Ken-ichi Hirano, Takashi Kamiya, Shohei Yoshida, Shintaro Saito, Seigo Kinuya

PDF-Version jetzt herunterladen Zum Volltext

28.09.2022 | Short Communication

Attenuation correction for phantom tests: an alternative to maximum-likelihood attenuation correction factor-based correction for clinical studies in time-of-flight PET

Tetsuro Mizuta, Yoshiyuki Yamakawa, Suzuka Minagawa, Tetsuya Kobayashi, Atsushi Ohtani, Shiho Takenouchi, Kohei Hanaoka, Shota Watanabe, Daisuke Morimoto-Ishikawa, Takahiro Yamada, Hayato Kaida, Kazunari Ishii

Springer Medizin

Annals of Nuclear Medicine

Ausgabe 11/2022

Inhaltsverzeichnis (8 Artikel)

Identification of patients with Graves’ disease who benefit from high-dose radioactive iodine therapy

PD1 blockade alters cell-cycle distribution and affects 3′-deoxy-3′-[18F]fluorothymidine uptake in a mouse CT26 tumor model

New index to assess the extent of bone disease in patients with prostate cancer using SPECT/CT

Semiquantitative analysis using whole-body dynamic F-18 fluoro-2-deoxy-glucose–positron emission tomography to differentiate between benign and malignant lesions

Role of baseline 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting survival outcomes of metastatic castration-resistant prostate cancer patients receiving first-line treatment

[99mTc]-labeling and evaluation of a new linear peptide for imaging of glioblastoma as a αvβ3-positive tumor

Methods of calculating 123I-β-methyl-P-iodophenyl-pentadecanoic acid washout rates in triglyceride deposit cardiomyovasculopathy

Attenuation correction for phantom tests: an alternative to maximum-likelihood attenuation correction factor-based correction for clinical studies in time-of-flight PET

Aktuelle Ausgaben

Ausgabe 1/2023

Ausgabe 12/2022

Ausgabe 11/2022

Ausgabe 10/2022

Ausgabe 9/2022

Ausgabe 8/2022

Ausgabe 7/2022

Ausgabe 6/2022

Ausgabe 5/2022

Ausgabe 4/2022